These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8011977)

  • 1. Angiotensin II: endothelium-derived nitric oxide interaction in conscious rats.
    Sigmon DH; Newman JM; Beierwaltes WH
    J Am Soc Nephrol; 1994 Mar; 4(9):1675-82. PubMed ID: 8011977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma renin activity and the renal response to nitric oxide synthesis inhibition.
    Sigmon DH; Carretero OA; Beierwaltes WH
    J Am Soc Nephrol; 1992 Dec; 3(6):1288-94. PubMed ID: 1477324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal nitric oxide and angiotensin II interaction in renovascular hypertension.
    Sigmon DH; Beierwaltes WH
    Hypertension; 1993 Aug; 22(2):237-42. PubMed ID: 8340159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin II: nitric oxide interaction and the distribution of blood flow.
    Sigmon DH; Beierwaltes WH
    Am J Physiol; 1993 Dec; 265(6 Pt 2):R1276-83. PubMed ID: 8285267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin dependence of endothelium-mediated renal hemodynamics.
    Sigmon DH; Carretero OA; Beierwaltes WH
    Hypertension; 1992 Nov; 20(5):643-50. PubMed ID: 1330922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Halothane impairs the hemodynamic influence of endothelium-derived nitric oxide.
    Sigmon DH; Florentino-Pineda I; Van Dyke RA; Beierwaltes WH
    Anesthesiology; 1995 Jan; 82(1):135-43. PubMed ID: 7832295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal versus femoral hemodynamic response to endothelium-derived relaxing factor synthesis inhibition.
    Sigmon DH; Carretero OA; Beierwaltes WH
    J Vasc Res; 1993; 30(4):218-23. PubMed ID: 8357952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin II and alpha 1-adrenergic tone in chronic nitric oxide blockade-induced hypertension.
    Qiu C; Engels K; Baylis C
    Am J Physiol; 1994 May; 266(5 Pt 2):R1470-6. PubMed ID: 8203622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of nitric oxide in the chronic phase of two-kidney, one clip renovascular hypertension.
    Sigmon DH; Beierwaltes WH
    Hypertension; 1998 Feb; 31(2):649-56. PubMed ID: 9461236
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tonic stimulation of renin gene expression by nitric oxide is counteracted by tonic inhibition through angiotensin II.
    Schricker K; Hegyi I; Hamann M; Kaissling B; Kurtz A
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):8006-10. PubMed ID: 7644529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal effects of acute endothelial-derived relaxing factor blockade are not mediated by angiotensin II.
    Baylis C; Engels K; Samsell L; Harton P
    Am J Physiol; 1993 Jan; 264(1 Pt 2):F74-8. PubMed ID: 8430832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of renal vasoconstrictor effect of NG-nitro-L-arginine in rabbit by angiotensin II and alpha-1 adrenergic receptor blockade.
    Hajj-Ali AF; Reilly TM; Wong PC
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1152-7. PubMed ID: 7932165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
    Gardiner SM; Compton AM; Kemp PA; Bennett T; Foulkes R; Hughes B
    Br J Pharmacol; 1991 May; 103(1):1256-62. PubMed ID: 1878760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitric oxide and the depressor response to angiotensin blockade in hypertension.
    Guan H; Cachofeiro V; Pucci ML; Kaminski PM; Wolin MS; Nasjletti A
    Hypertension; 1996 Jan; 27(1):19-24. PubMed ID: 8591882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sodium and angiotensin in hypertension induced by long-term nitric oxide blockade.
    Jover B; Herizi A; Ventre F; Dupont M; Mimran A
    Hypertension; 1993 Jun; 21(6 Pt 2):944-8. PubMed ID: 8505104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
    Nafrialdi N; Jover B; Mimran A
    J Cardiovasc Pharmacol; 1994 May; 23(5):765-71. PubMed ID: 7521459
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of adenosine A1 receptor-mediated renal vasoconstriction with endogenous nitric oxide and ANG II.
    Barrett RJ; Droppleman DA
    Am J Physiol; 1993 Nov; 265(5 Pt 2):F651-9. PubMed ID: 8238545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats.
    Siragy HM; Carey RM
    J Clin Invest; 1997 Jul; 100(2):264-9. PubMed ID: 9218502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Contribution of the renin-angiotensin system to the variability of blood pressure in hypertensive rat after blockade of nitric oxide synthesis].
    Gouédard O; Gaudet E; Blanc J; Ponchon P; Elghozi JL
    Arch Mal Coeur Vaiss; 1996 Aug; 89(8):1013-7. PubMed ID: 8949370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inhibition of nitric oxide synthesis. A new model of arterial hypertension.
    Ribeiro MO; Antunes E; de Nucci G; Lovisolo SM; Zatz R
    Hypertension; 1992 Sep; 20(3):298-303. PubMed ID: 1516948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.